title: Diffuse bone increase uptake of gallium-67 related to cyclophosphamide and recombinant human granulocyte-colony stimulating factor (rHuG-CSF) administration.
authors.affiliation: Clinic Universitary Hospital, University of Valencia, Spain.
authors.forename: G
authors.initials: G
authors.lastname: Ruíz-Hernández
authors.forename: C
authors.initials: C
authors.lastname: Solano-Vercet
authors.forename: M J
authors.initials: MJ
authors.lastname: Terol-Castera
authors.forename: E
authors.initials: E
authors.lastname: Rodilla Sala
authors.forename: F J
authors.initials: FJ
authors.lastname: Castillo-Pallarés
authors.forename: J V
authors.initials: JV
authors.lastname: Balaguer-Martínez
authors.forename: A
authors.initials: A
authors.lastname: Mateo-Navarro
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001842:Bone and Bones / Q000000981:diagnostic imaging*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000009:adverse effects*; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005710:Gallium Radioisotopes / Q000493:pharmacokinetics*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D011877:Radionuclide Imaging; D011994:Recombinant Proteins; D014018:Tissue Distribution
chemical_list: D005710:Gallium Radioisotopes; D011994:Recombinant Proteins; D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D005047:Etoposide; D003520:Cyclophosphamide; D002945:Cisplatin; D008775:Methylprednisolone